KF
REGN icon

Krilogy Financial’s Regeneron Pharmaceuticals REGN Stock Holding History

Krilogy Financial’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.17M Sell
1,878
-565
-23% -$385K 0.03% 343
2026
Q1 		$1.82M Sell
2,443
-33
-1% -$25.3K 0.06% 235
2025
Q4 		$1.89M Buy
2,476
+385
+18% +$261K 0.06% 222
2025
Q3 		$1.35M Buy
+2,091
New +$1.18M 0.05% 265

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Krilogy Financial's REGN Position: Q2 2026 in Review

Krilogy Financial reduced its Regeneron Pharmaceuticals (REGN) stake by 23% in Q2 2026, selling an estimated $385K and leaving 1,878 shares worth $1.17M. The position accounts for 0.03% of the portfolio, ranked #343.

Krilogy Financial first reported a position in REGN in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.89M in Q4 2025. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Krilogy Financial held 1,878 shares of Regeneron Pharmaceuticals worth $1.17M as of Q2 2026.
  • Krilogy Financial sold 565 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $385K.
  • Regeneron Pharmaceuticals made up 0.03% of Krilogy Financial's portfolio in Q2 2026, its #343 holding.
  • Krilogy Financial first reported a position in Regeneron Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Krilogy Financial's Regeneron Pharmaceuticals position peaked at $1.89M in Q4 2025.
  • 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Krilogy Financial's 13F filing for Q2 2026, filed 27 Jul 2026.